These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38284293)
41. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
42. Tanshinone IIA protects intestinal epithelial cells from deoxynivalenol-induced pyroptosis. Zhang C; Chen F; Wang Y; Zhang K; Yang X; Wang X Ecotoxicol Environ Saf; 2024 Jan; 269():115743. PubMed ID: 38035519 [TBL] [Abstract][Full Text] [Related]
43. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of tanshinone IIA on rat hepatic stellate cells. Liu YW; Huang YT PLoS One; 2014; 9(7):e103229. PubMed ID: 25076488 [TBL] [Abstract][Full Text] [Related]
45. Tanshinone IIA pretreatment promotes cell survival in human lung epithelial cells under hypoxia via AP-1-Nrf2 transcription factor. Yadav S; Singh M; Singh SN; Kumar B Cell Stress Chaperones; 2020 May; 25(3):427-440. PubMed ID: 32144684 [TBL] [Abstract][Full Text] [Related]
46. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674 [TBL] [Abstract][Full Text] [Related]
47. Extracellular CIRP Upregulates Proinflammatory Cytokine Expression via the NF-kappaB and ERK1/2 Signaling Pathways in Psoriatic Keratinocytes. Zhang X; Wang S; Wang W; Song L; Feng S; Wang J; Kang T; Yang P; Wang N; Yang P; Bai R; Shao Y; Zheng Y Mediators Inflamm; 2022; 2022():5978271. PubMed ID: 36110097 [TBL] [Abstract][Full Text] [Related]
48. Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB/c mice. Singh VK; Sahoo D; Agrahari K; Khan A; Mukhopadhyay P; Chanda D; Yadav NP Life Sci; 2023 Sep; 328():121909. PubMed ID: 37414141 [TBL] [Abstract][Full Text] [Related]
49. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice. Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197 [TBL] [Abstract][Full Text] [Related]
50. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194 [TBL] [Abstract][Full Text] [Related]
51. CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-κB signaling for the treatment of psoriasis. Zhao J; Chen Y; Li L; Yin H; Song S; Wang Y; Feng X; Fan X; Gao C; Gao L; Zhan Y; Zhao M; Li X; Lu Q Int J Biol Sci; 2024; 20(6):2168-2186. PubMed ID: 38617532 [TBL] [Abstract][Full Text] [Related]
52. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway. Shi Q; He Q; Chen W; Long J; Zhang B J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279 [TBL] [Abstract][Full Text] [Related]
53. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639 [TBL] [Abstract][Full Text] [Related]
55. The Impact of Proinflammatory Cytokines and Imiquimod on GLUT1 in HaCaT Keratinocytes - a Potential Anti-Psoriatic Therapeutic Target? Makuch S; Kupczyk P; Makarec A; Chodaczek G; Ziółkowski P; Woźniak M Cell Physiol Biochem; 2023 Mar; 57(2):54-62. PubMed ID: 36945896 [TBL] [Abstract][Full Text] [Related]
56. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice. Zhao K; Pu S; Sun L; Zhou D Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802 [TBL] [Abstract][Full Text] [Related]
57. Secoemestrin C Ameliorates Psoriasis-like Skin Inflammation in Mice by Suppressing the TNF-α/NF-κB Signaling Pathway. Zhu ZB; Liu MJ; Wang J; Shu Z; Cao J Curr Med Sci; 2024 Feb; 44(1):232-240. PubMed ID: 38393530 [TBL] [Abstract][Full Text] [Related]
58. Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer's disease. Li J; Wen PY; Li WW; Zhou J Neuroreport; 2015 Sep; 26(13):758-66. PubMed ID: 26164608 [TBL] [Abstract][Full Text] [Related]
59. GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway. Gao Y; Zhan W; Guo D; Lin H; Farooq MA; Jin C; Zhang L; Zhou Y; Yao J; Duan Y; He C; Jiang S; Jiang W Biomed Pharmacother; 2024 Oct; 179():117431. PubMed ID: 39260323 [TBL] [Abstract][Full Text] [Related]
60. Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway. Fan G; Jiang X; Wu X; Fordjour PA; Miao L; Zhang H; Zhu Y; Gao X Inflammation; 2016 Feb; 39(1):375-384. PubMed ID: 26639663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]